Clinical Trial Update: Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating two non-invasive techniques to monitor clearance of actinic keratosis lesions; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED